Form4insider filings, from the source

SEC Form 4 · accession 0001061983-26-000094

CYTOKINETICS INC · CYTK

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Robert I Blum
Officer — President & CEO · Director
Period of report
Sep 14, 2026
Accepted (ET)
Sep 15, 2026 · 5:20 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001061983

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockSep 14, 2026M7,500$10.60A385,320D
Common StockSep 14, 2026S7,500$73.44D377,820D
Common StockSep 14, 2026G1,350$0.00D376,470D
Common StockSep 14, 2026G97,926$0.00D278,544D
Common StockSep 14, 2026G97,926$0.00A97,926Iby Trust 3. Beneficial Ownership Disclaimed.
Common StockSep 15, 2026S97,926$69.33D0Iby Trust 3. Beneficial Ownership Disclaimed.
Common StockF7holding———2,083Iby Trust 1. Beneficial Ownership disclaimed.
Common StockF8holding———2,083Iby Trust 2. Beneficial Ownership Disclaimed.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Non-Qualified Stock Option (Right to Buy)$10.60Sep 14, 2026M7,500DMar 28, 2017Feb 28, 2027Common Stock7,500156,745D

Explanation of responses